The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies (GS-PET-2008)

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Urological Malignancies

Study type

Observational

Funder types

Other

Identifiers

NCT00706212
GS-PET-2008

Details and patient eligibility

About

PET CT is one of the imaging tools that are used for staging of urological malignancies. C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed ~95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients older then 18 years of age
  • Full consciousness and awareness
  • suspected to suffer from urological malignancy and a candidate for a surgical procedur

Exclusion criteria

known secondary malignancy

Trial contacts and locations

0

Loading...

Central trial contact

Shay Golan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems